Peptilogics
Rebecca Lukens has a diverse background in administrative roles, ranging from supporting occupational safety professionals to managing contracts and licensing for agents and brokers. With experience in both nonprofit and corporate settings, Rebecca has honed their skills in calendar management, database maintenance, and event coordination. Rebecca holds an Associate's Degree in Photography and has a passion for supporting others in their professional growth.
This person is not in any teams
Peptilogics
Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space, but ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics' lead clinical stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.